Sensus Healthcare Launches Collaboration with BirchBioMed sensushealthcare.com/press-release/…
English
BirchBioMed
11 posts
BirchBioMed
@BirchBioMed
BirchBioMed Inc. is exclusively licenced by the University of British Columbia to develop anti-scarring drugs and autoimmune therapies based on FS2
Toronto, Vancouver, New York Katılım Ağustos 2016
18 Takip Edilen44 Takipçiler
BirchBioMed retweetledi
Times Square spotlight shines on @UBC spin-off company @birchbiomed's anti-scarring drug developed at @VCHResearch
English
@BioPrecision
Look forward to talking. Can you DM us an email address?
English
BirchBioMed in New York City! Dr. Ghahary and Dr. Hartwell on the sign in Times Square #clinicaltrials #AntiScarring
English
BirchBioMed retweetledi
.@BirchBioMed announces completion of #clinicaltrial for ground-breaking anti-scarring #drug dld.bz/eRwCs
English
BirchBioMed retweetledi
.@BirchBioMed announces completion of #clinicaltrial for ground-breaking anti-scarring #drug dld.bz/eRwCs
English
BirchBioMed retweetledi
.@BirchBioMed announces completion of #clinicaltrial for ground-breaking anti-scarring #drug dld.bz/eRwCs
English
BirchBioMed announces completion of clinical trial for ground-breaking anti-scarring drug lnkd.in/ebsvUtx
English
BirchBioMed retweetledi
BirchBioMed's ground-breaking therapeutics in the news @BirchBioMed #scarring #autoimmune #biomedical twitter.com/BirchBioMed/st…
BirchBioMed@BirchBioMed
BirchBioMed announces completion of clinical trial for ground-breaking anti-scarring drug bit.ly/2boNZmu
English
BirchBioMed announces completion of clinical trial for ground-breaking anti-scarring drug bit.ly/2boNZmu
English